Form 4 for OABI OmniAb, Inc.
Accepted 2022-11-03 00:00:00 ET · period of report 2022-11-01 · accession 0000899243-22-035063 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-11-03 | 2022-11-01 | OABI | Berkman Charles S | See Remarks | A - Grant | — | +353.7K | 353.7K | New | — |
| DM | 2022-11-03 | 2022-11-01 | OABI | Berkman Charles S | See Remarks | A - Grant | — | +436.8K | 29.8K | New | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-11-01 | A | A | 353,716 | — | 353,716 | D | — | — | (F3) Includes 96,038 earn-out shares subject to forfeiture provisions described in the Merger Agreement. (F2) Includes 97,769 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock and does not expire. (F1) Pursuant to the business combination of Avista Public Acquisition Corp. II and OmniAb, Inc. ("Legacy OmniAb"), as contemplated by an agreement and plan of merger, dated March 23, 2022 (the "Merger Agreement"), each share of common stock, option and award of restricted stock unit of Legacy OmniAb automatically converted into the right to receive securities of the Issuer with the same terms and conditions in accordance with an exchange ratio described in the Merger Agreement. |
| 2 | Derivative | Stock Option | 2022-11-01 | A | A | 62,710 | — | 62,710 | D | $13.54 · — to 2029-02-11 | 62,710 Common Stock | (F1) Pursuant to the business combination of Avista Public Acquisition Corp. II and OmniAb, Inc. ("Legacy OmniAb"), as contemplated by an agreement and plan of merger, dated March 23, 2022 (the "Merger Agreement"), each share of common stock, option and award of restricted stock unit of Legacy OmniAb automatically converted into the right to receive securities of the Issuer with the same terms and conditions in accordance with an exchange ratio described in the Merger Agreement. (F5) The stock option vests and is exercisable as to 12.5% of the underlying shares on August 11, 2019, and in 42 substantially equal monthly installments thereafter. |
| 3 | Derivative | Stock Option | 2022-11-01 | A | A | 39,777 | — | 39,777 | D | $18.24 · — to 2028-03-02 | 39,777 Common Stock | (F1) Pursuant to the business combination of Avista Public Acquisition Corp. II and OmniAb, Inc. ("Legacy OmniAb"), as contemplated by an agreement and plan of merger, dated March 23, 2022 (the "Merger Agreement"), each share of common stock, option and award of restricted stock unit of Legacy OmniAb automatically converted into the right to receive securities of the Issuer with the same terms and conditions in accordance with an exchange ratio described in the Merger Agreement. (F4) The stock option is fully vested and exercisable. |
| 4 | Derivative | Stock Option | 2022-11-01 | A | A | 29,237 | — | 29,237 | D | $11.52 · — to 2027-02-24 | 29,237 Common Stock | (F1) Pursuant to the business combination of Avista Public Acquisition Corp. II and OmniAb, Inc. ("Legacy OmniAb"), as contemplated by an agreement and plan of merger, dated March 23, 2022 (the "Merger Agreement"), each share of common stock, option and award of restricted stock unit of Legacy OmniAb automatically converted into the right to receive securities of the Issuer with the same terms and conditions in accordance with an exchange ratio described in the Merger Agreement. (F4) The stock option is fully vested and exercisable. |
| 5 | Derivative | Stock Option | 2022-11-01 | A | A | 73,716 | — | 73,716 | D | $10.98 · — to 2030-02-13 | 73,716 Common Stock | (F1) Pursuant to the business combination of Avista Public Acquisition Corp. II and OmniAb, Inc. ("Legacy OmniAb"), as contemplated by an agreement and plan of merger, dated March 23, 2022 (the "Merger Agreement"), each share of common stock, option and award of restricted stock unit of Legacy OmniAb automatically converted into the right to receive securities of the Issuer with the same terms and conditions in accordance with an exchange ratio described in the Merger Agreement. (F6) The stock option vests and is exercisable as to 12.5% of the underlying shares on August 13, 2020, and in 42 substantially equal monthly installments thereafter. |
| 6 | Derivative | Stock Option | 2022-11-01 | A | A | 17,778 | — | 17,778 | D | $9.84 · — to 2026-02-11 | 17,778 Common Stock | (F1) Pursuant to the business combination of Avista Public Acquisition Corp. II and OmniAb, Inc. ("Legacy OmniAb"), as contemplated by an agreement and plan of merger, dated March 23, 2022 (the "Merger Agreement"), each share of common stock, option and award of restricted stock unit of Legacy OmniAb automatically converted into the right to receive securities of the Issuer with the same terms and conditions in accordance with an exchange ratio described in the Merger Agreement. (F4) The stock option is fully vested and exercisable. |
| 7 | Derivative | Stock Option | 2022-11-01 | A | A | 175,477 | — | 175,477 | D | $10.41 · — to 2032-05-05 | 175,477 Common Stock | (F1) Pursuant to the business combination of Avista Public Acquisition Corp. II and OmniAb, Inc. ("Legacy OmniAb"), as contemplated by an agreement and plan of merger, dated March 23, 2022 (the "Merger Agreement"), each share of common stock, option and award of restricted stock unit of Legacy OmniAb automatically converted into the right to receive securities of the Issuer with the same terms and conditions in accordance with an exchange ratio described in the Merger Agreement. (F8) The stock option vests and is exercisable as to 12.5% of the underlying shares on August 5, 2022, and in 42 substantially equal monthly installments thereafter. |
| 8 | Derivative | Stock Option | 2022-11-01 | A | A | 8,339 | — | 8,339 | D | $6.46 · — to 2025-02-10 | 8,339 Common Stock | (F1) Pursuant to the business combination of Avista Public Acquisition Corp. II and OmniAb, Inc. ("Legacy OmniAb"), as contemplated by an agreement and plan of merger, dated March 23, 2022 (the "Merger Agreement"), each share of common stock, option and award of restricted stock unit of Legacy OmniAb automatically converted into the right to receive securities of the Issuer with the same terms and conditions in accordance with an exchange ratio described in the Merger Agreement. (F4) The stock option is fully vested and exercisable. |
| 9 | Derivative | Stock Option | 2022-11-01 | A | A | 29,772 | — | 29,772 | D | $20.36 · — to 2031-02-03 | 29,772 Common Stock | (F1) Pursuant to the business combination of Avista Public Acquisition Corp. II and OmniAb, Inc. ("Legacy OmniAb"), as contemplated by an agreement and plan of merger, dated March 23, 2022 (the "Merger Agreement"), each share of common stock, option and award of restricted stock unit of Legacy OmniAb automatically converted into the right to receive securities of the Issuer with the same terms and conditions in accordance with an exchange ratio described in the Merger Agreement. (F7) The stock option vests and is exercisable as to 12.5% of the underlying shares on August 3, 2021, and in 42 substantially equal monthly installments thereafter. |